InsidersTradesSigma
에스케이바이오팜: directors' dealings · South Korea · DART (FSS)
DART:company-c5a1eaKR·DART (FSS)Mcap 7478.9Bn€Healthcare
Explore the full insider trade history of 에스케이바이오팜, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 에스케이바이오팜 has published 1 insider filings. Market capitalisation: €7,478.9bn. The latest transaction was disclosed on 1 April 2026 — Sale. Among the most active insiders: 국민연금공단. Every trade is accessible without an account.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
95500.00 €
Analyst consensus
13 analystsBuy
73000.00 €Target 142923.08 €(+50%)165000.00 €
Income statement
Revenue706.74 Bn€
Gross profit663.84 Bn€94% margin
Net income266.95 Bn€37.8% margin
Valuation
PER (forward)20.6x
Beta0.80
Balance sheet & cash
Market cap7478.92 Bn€
Total debt48.92 Bn€
Free Cash Flow146.82 Bn€
Debt / Equity6%
Profitability & ownership
ROE36.2%
ROA11.4%
% insiders50.2%
% institutions14.2%
Last declaration on 1 April 2026